Lin Lv
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Metal complexes synthesis and properties
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- Gut microbiota and health 2
- Oncology 11
- Cancer Cells and Metastasis 3
- Metal complexes synthesis and properties 3
- Co-authors
- Haiguang Liu (4 shared papers)Jian‐Chuan Xia (8 shared papers)Ke Pan (6 shared papers)Wukun Liu (3 shared papers)Li Chai (1 shared paper)Qing Xu (1 shared paper)Zongcheng Yang (1 shared paper)Fen Liu (1 shared paper)
- Journals
- PLoS ONE (7 papers)Medicine (3 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Infection Genetics and Evolution (2 papers)Drug Design Development and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Lv
66 papers receiving 2.1k citations
Lin Lv's Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 328
- Oncology 475
- Immunology 314
- Gastroenterology 71
- Pulmonary and Respiratory Medicine 347
Countries citing papers authored by Lin Lv
This map shows the geographic impact of Lin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lv more than expected).
Fields of papers citing papers by Lin Lv
This network shows the impact of papers produced by Lin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lv. The network helps show where Lin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer Hit paper breakdown → | 2022 | 319 |
| 2 | Recent development of gold( Hit paper breakdown → | 2022 | 190 |
| 3 | 2011 | 112 | |
| 4 | 2012 | 108 | |
| 5 | 2011 | 89 | |
| 6 | 2015 | 85 | |
| 7 | 2009 | 79 | |
| 8 | 2010 | 77 | |
| 9 | Chemotherapy targeting cancer stem cells. | 2015 | 75 |
| 10 | 2016 | 67 | |
| 11 | 2016 | 67 | |
| 12 | 2012 | 53 | |
| 13 | 2015 | 52 | |
| 14 | 2015 | 44 | |
| 15 | 2013 | 39 | |
| 16 | 2015 | 38 | |
| 17 | 2017 | 38 | |
| 18 | 2011 | 37 | |
| 19 | 2013 | 36 | |
| 20 | 2018 | 35 |
About Lin Lv
Lin Lv is a scholar working on Molecular Biology, Oncology, Surgery, Gastroenterology and Epidemiology, having authored 70 papers that have together received 2.2k indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (6 papers), Cancer Cells and Metastasis (3 papers), Gastroesophageal reflux and treatments (3 papers), Autophagy in Disease and Therapy (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Metal complexes synthesis and properties (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Cancer Research (328 citations), Oncology (475 citations), Immunology (314 citations), Gastroenterology (71 citations) and Pulmonary and Respiratory Medicine (347 citations). Lin Lv has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Haiguang Liu, Jian‐Chuan Xia, Ke Pan, Wukun Liu, Li Chai, Qing Xu, Zongcheng Yang, Fen Liu, Jihui Jia and Xiuming Liang. Their work appears in journals such as PLoS ONE, Medicine, Evidence-based Complementary and Alternative Medicine, Infection Genetics and Evolution and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.